ArticleFrontiers in pharmacology2023

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells.

Hai-Ling Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.